Developing an automated robotic factory for novel stem cell therapy production
Editorial discussing the need for new, advanced manufacturing platforms to be developed in order for advanced stem cell therapies, that is, cell and gene therapies, to achieve widespread clinical application, by Qasim A Rafiq, Karen Twomey, Michael Kulik et al. (from various organizations such as Fraunhofer Institute for Production Technology IPT in Germany and Cell & Gene Therapy Catapult in the UK).
Please sign in or register for FREE
Sign in to RegMedNet
Not yet a member? Become a member FREE to:
- Get unlimited access to ALL CONTENT
- Read selected articles from journals such as Regenerative Medicine FREE
- Receive a weekly email roundup of the latest news and expert opinions
Did you know?
Your RegMedNet account also gives you access to communities on drug discovery, real-world evidence and 3D printing in medicine. Find out more>>